Details for New Drug Application (NDA): 012111
✉ Email this page to a colleague
NDA 012111 describes MYDRIACYL, which is a drug marketed by Alcon, Alcon Labs Inc, and Sandoz, and is included in three NDAs. It is available from two suppliers. Additional details are available on the MYDRIACYL profile page.
The generic ingredient in MYDRIACYL is tropicamide. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the tropicamide profile page.
The generic ingredient in MYDRIACYL is tropicamide. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the tropicamide profile page.
Summary for 012111
| Tradename: | MYDRIACYL |
| Applicant: | Alcon |
| Ingredient: | tropicamide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012111
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
